Overview

North America IVD Market is poised to value over USD 35.2 billion by 2027 end at a CAGR of over 4.5% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of North America IVD Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the North America IVD Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the North America IVD Market:
• Abbott Laboratories
• Johnson and Johnson
• Siemens Healthineers
• Becton Dickinson and Company
• F.Hoffmann-La Roche (Roche)
• Beckman Coulter
• BioMerieux S.A.
• Ortho Clinical Dignostics, Inc
• Bio-Rad Laboratories
• Danaher Corporation
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Qiagen N.V.
(Note: The list of the major players will be updated with the latest market scenario and trends)

North America IVD Market Segmentation:
By Product
• Instruments
• Kits
• Reagents
• Software

By Technology 
• Clinical Chemistry
• Hematology
• Immunoassay
• Coagulation and Hemostasis
• Molecular Diagnostics
• Microbiology 
• Other IVD Technology
  
By Applications 
• Diabetes
• Infectious Disease
• Oncology/Cancer
• Cardiology
• Nephrology
• Autoimmune Disease
• Drug Testing 
• HIV

By Region
• U.S.A
• Canada
• Mexico

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the North America IVD Market By Product, By Technology, By Applications and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— U.S.A, Canada, Mexico.
• To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1 Objectives of the Study 
   1.2 Market Definition 
   1.3 Market Scope 
       1.3.1 Years Considered for the Study
       1.3.2 Market Covered
   1.4 Currency 
   1.5 Limitations 
   1.6 Stakeholders 

2. Research Methodology 
    2.1 Research Data 
        2.1.1 Secondary Data
              2.1.1.1 Key Data from Secondary Sources
        2.1.2 Primary Data
              2.1.2.1 Key Data from Primary Sources
    2.2 Market Size Estimation 
    2.3 Market Breakdown and Data Triangulation 
    2.4 Assumptions for the Study  

3. Executive Summary
   3.1 Market Outlook
   3.2 Segment Outlook
   3.3 Competitive Insights

4.  North America IVD Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of North America IVD Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6.  North America IVD Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. North America IVD Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
   7.1. Instruments
   7.2. Kits
   7.3. Reagents
   7.4. Software
   
8. North America IVD Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)  
   8.1. Clinical Chemistry
   8.2. Hematology
   8.3. Immunoassay
   8.4. Coagulation and Hemostasis
   8.5. Molecular Diagnostics
   8.6. Microbiology
   8.7. Other IVD Technology
       
9.  North America IVD Market, By Applications Historical Analysis and Forecast 2020-2027 (USD Million)  
   9.1. Diabetes
   9.2. Infectious Disease
   9.3. Oncology/Cancer
   9.4. Cardiology
   9.5. Nephrology
   9.6. Autoimmune Disease
   9.7. Drug Testing 
   9.8. HIV
   
10. North America IVD Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million)
   10.1. Introduction
   10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019
        10.2.1. U.S.A
        10.2.2. Canada
        10.2.3. Mexico
   10.3. Market Size (USD Million) Forecast for North America 2020-2027

11. Market Share Analysis and Competitive Landscape   
    11.1. North America Landscape - Key Players, Revenue and Presence
    11.2. North America Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    11.3. North America Emerging Companies
    11.4.  North America - Market Share Analysis and Key Regional Players
    11.7.  North America Key Player - Growth Matrix

12. Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts)
    12.1. Abbott Laboratories
          12.1.1. Company Overview
          12.1.2. Product Portfolio
          12.1.3. SWOT Analysis
          12.1.4. Financial Overview
          12.1.5. Strategic Overview
    12.2. Johnson and Johnson
          12.2.1. Company Overview
          12.2.2. Product Portfolio
          12.2.3. SWOT Analysis
          12.2.4. Financial Overview
          12.2.5. Strategic Overview 
    12.3. Siemens Healthineers
          12.3.1. Company Overview
          12.3.2. Product Portfolio
          12.3.3. SWOT Analysis
          12.3.4. Financial Overview
          12.3.5. Strategic Overview
    12.4. Becton Dickinson and Company
          12.4.1. Company Overview
          12.4.2. Product Portfolio
          12.4.3. SWOT Analysis
          12.4.4. Financial Overview
          12.4.5. Strategic Overview
    12.5. F.Hoffmann-La Roche (Roche)
          12.5.1. Company Overview
          12.5.2. Product Portfolio
          12.5.3. SWOT Analysis
          12.5.4. Financial Overview
          12.5.5. Strategic Overview          
    12.6. Beckman Coulter
          12.6.1. Company Overview
          12.6.2. Product Portfolio
          12.6.3. SWOT Analysis
          12.6.4. Financial Overview
          12.6.5. Strategic Overview      
    12.7. BioMerieux S.A.
          12.7.1. Company Overview
          12.7.2. Product Portfolio
          12.7.3. SWOT Analysis
          12.7.4. Financial Overview
          12.7.5. Strategic Overview
    12.8. Ortho Clinical Dignostics, Inc
          12.8.1. Company Overview
          12.8.2. Product Portfolio
          12.8.3. SWOT Analysis
          12.8.4. Financial Overview
          12.8.5. Strategic Overview 
    12.9. Bio-Rad Laboratories.
          12.9.1. Company Overview
          12.9.2. Product Portfolio
          12.9.3. SWOT Analysis
          12.9.4. Financial Overview
          12.9.5. Strategic Overview 
    12.10.Danaher Corporation
          12.10.1. Company Overview
          12.10.2. Product Portfolio
          12.10.3. SWOT Analysis
          12.10.4. Financial Overview
          12.10.5. Strategic Overview 
    12.11.Sysmex Corporation
          12.11.1. Company Overview
          12.11.2. Product Portfolio
          12.11.3. SWOT Analysis
          12.11.4. Financial Overview
          12.11.5. Strategic Overview 
    12.12.Thermo Fisher Scientific Inc.
          12.12.1. Company Overview
          12.12.2. Product Portfolio
          12.12.3. SWOT Analysis
          12.12.4. Financial Overview
          12.12.5. Strategic Overview 
    12.13.Qiagen N.V.
          12.13.1. Company Overview
          12.13.2. Product Portfolio
          12.13.3. SWOT Analysis
          12.13.4. Financial Overview
          12.13.5. Strategic Overview 
  
13. Pre and Post COVID-19 Impact
    13.1. Positive influence on the healthcare industry
    13.2. The financial disruption of the manufacturing sector
    13.3. Impact of COVID-19 on emerging companies
    13.4. Significant mandates in the healthcare regulations initiated by administrations
    13.5. The overall economic slowdown of the developing and developed nations

14. FutureWise SME Key Takeaway Points for Client

Tables

Figures